Skip Header

23 results for author:"Davis J.A." in Literature citations

Page 1 of 1

to top of page·  

Results Customize

› Repeat search in UniProtKB (28)

An S-opsin knock-in mouse (F81Y) reveals a role for the native ligand 11-cis-retinal in cone opsin biosynthesis.

Insinna C., Daniele L.L., Davis J.A., Larsen D.D., Kuemmel C., Wang J., Nikonov S.S., Knox B.E., Pugh E.N. Jr.

J. Neurosci. 32:8094-8104(2012) · Mapped (3)

Discovery of a series of imidazo[4,5-b]pyridines with dual activity at angiotensin II type 1 receptor and peroxisome proliferator-activated receptor-gamma.

Casimiro-Garcia A., Filzen G.F., Flynn D., Bigge C.F., Chen J., Davis J.A., Dudley D.A., Edmunds J.J., Esmaeil N., Geyer A. et al.

J. Med. Chem. 54:4219-4233(2011) · Mapped (1)

Competitive enhancement of HGF-induced epithelial scattering by accessory growth factors.

Chung J.Y., Davis J.A., Price B.D., Staley D.M., Wagner M.V., Warner S.L., Bearss D.J., Hansen M.D.

Exp. Cell Res. 317:307-318(2011) · Mapped (1)

Influence of tumour necrosis factor-alpha polymorphism-308 and atopy on irritant contact dermatitis in healthcare workers.

Davis J.A., Visscher M.O., Wickett R.R., Hoath S.B.

Contact Derm. 63:320-332(2010) · Mapped (6)

Role of TNF-alpha polymorphism -308 in neurosensory irritation.

Davis J.A., Visscher M.O., Wickett R.R., Hoath S.B.

Int J Cosmet Sci 33:105-112(2011) · Mapped (6)

Synthesis and evaluation of novel alpha-heteroaryl-phenylpropanoic acid derivatives as PPARalpha/gamma dual agonists.

Casimiro-Garcia A., Bigge C.F., Davis J.A., Padalino T., Pulaski J., Ohren J.F., McConnell P., Kane C.D., Royer L.J., Stevens K.A. et al.

Bioorg. Med. Chem. 17:7113-7125(2009) · Mapped (1)

Glycogen synthase kinase 3: more than a namesake.

Rayasam G.V., Tulasi V.K., Sodhi R., Davis J.A., Ray A.

Br. J. Pharmacol. 156:885-898(2009) · UniProtKB (2)

Hippocampal nAChRs mediate nicotine withdrawal-related learning deficits.

Davis J.A., Gould T.J.

Eur Neuropsychopharmacol 19:551-561(2009) · Mapped (5)

Mouse cones require an arrestin for normal inactivation of phototransduction.

Nikonov S.S., Brown B.M., Davis J.A., Zuniga F.I., Bragin A., Pugh E.N. Jr., Craft C.M.

Neuron 59:462-474(2008) · Mapped (10)

Effects of modifications of the linker in a series of phenylpropanoic acid derivatives: Synthesis, evaluation as PPARalpha/gamma dual agonists, and X-ray crystallographic studies.

Casimiro-Garcia A., Bigge C.F., Davis J.A., Padalino T., Pulaski J., Ohren J.F., McConnell P., Kane C.D., Royer L.J., Stevens K.A. et al.

Bioorg. Med. Chem. 16:4883-4907(2008) · Mapped (1)

beta2 subunit-containing nicotinic receptors mediate the enhancing effect of nicotine on trace cued fear conditioning in C57BL/6 mice.

Davis J.A., Gould T.J.

Psychopharmacology (Berl.) 190:343-352(2007) · Mapped (10)

Ablation of mouse phosphomannose isomerase (Mpi) causes mannose 6-phosphate accumulation, toxicity, and embryonic lethality.

DeRossi C., Bode L., Eklund E.A., Zhang F., Davis J.A., Westphal V., Wang L., Borowsky A.D., Freeze H.H.

J. Biol. Chem. 281:5916-5927(2006) · Mapped (4)

Preponderance of free mediator in the yeast Saccharomyces cerevisiae.

Takagi Y., Chadick J.Z., Davis J.A., Asturias F.J.

J. Biol. Chem. 280:31200-31207(2005) · UniProtKB (20) · Mapped (1)

Pigmented paravenous chorioretinal atrophy is associated with a mutation within the crumbs homolog 1 (CRB1) gene.

McKay G.J., Clarke S., Davis J.A., Simpson D.A., Silvestri G.

Invest. Ophthalmol. Vis. Sci. 46:322-328(2005) · UniProtKB (1)

Cigarette smoke increases intimal hyperplasia and homocysteine in a rat carotid endarterectomy.

Davis J.A., Brown A.T., Chen H., Wang Y., Poirier L.A., Eidt J.F., Cruz C.P., Moursi M.M.

J. Surg. Res. 121:69-75(2004) · Mapped (2)

Beta class II tubulin predominates in normal and tumor breast tissues.

Dozier J.H., Hiser L., Davis J.A., Thomas N.S., Tucci M.A., Benghuzzi H.A., Frankfurter A., Correia J.J., Lobert S.

Breast Cancer Res. 5:R157-69(2003) · Mapped (7)

Structure of the yeast RNA polymerase II holoenzyme: mediator conformation and polymerase interaction.

Davis J.A., Takagi Y., Kornberg R.D., Asturias F.J.

Mol. Cell 10:409-415(2002) · UniProtKB (21) · Mapped (13)

Molecular cloning, gene organization, and expression of mouse Mpi encoding phosphomannose isomerase.

Davis J.A., Wu X.H., Wang L., DeRossi C., Westphal V., Wu R., Alton G., Srikrishna G., Freeze H.H.

Glycobiology 12:435-442(2002) · UniProtKB (1)

Genetic and metabolic analysis of the first adult with congenital disorder of glycosylation type Ib: long-term outcome and effects of mannose supplementation.

Westphal V., Kjaergaard S., Davis J.A., Peterson S.M., Skovby F., Freeze H.H.

Mol. Genet. Metab. 73:77-85(2001) · UniProtKB (1)

An Alzheimer's disease-linked PS1 variant rescues the developmental abnormalities of PS1-deficient embryos.

Davis J.A., Naruse S., Chen H., Eckman C., Younkin S., Price D.L., Borchelt D.R., Sisodia S.S., Wong P.C.

Neuron 20:603-609(1998) · Mapped (3)

Role of Olf-1 and Pax-6 transcription factors in neurodevelopment.

Davis J.A., Reed R.R.

J. Neurosci. 16:5082-5094(1996) · Mapped (33)

Expression of multiple forms of the prolactin receptor in mouse liver.

Davis J.A., Linzer D.I.H.

Mol. Endocrinol. 3:674-680(1989) · UniProtKB (2) · Mapped (11)

Mutational analysis of mouse placental lactogen II, and molecular characterization of the mouse prolactin receptor.

Davis J.A., Linzer D.I.

Prog. Clin. Biol. Res. 342:127-132(1990) · Mapped (13)

to top of page·

Page 1 of 1